definiens: means the period commencing on the Effective Date and ending on the earliest of : ( i ) dateon which [COMPANY] Initiates a Clinical Trial for ( a ) any Alpha4Beta2 Agonist other than a Collaboration Compound, Candidate Drug, Product or Licensed Derivative with respect to any of the foregoing, ( b ) any Other NNR Compoundthat is not ( i ) a Candidate Drug, Product or Licensed Derivative with respect to any of the foregoing or ( ii ) an OptionCompound for which [COMPANY] elects to assume and complete an Option Compound Development Plan pursuantto Section 5.10.2(b)(5 ) or ( c ) if [COMPANY] does not terminate this Agreement pursuant to Section 11.2.3, a productor compound that is the subject of a Competitive Program that [COMPANY] does not cease, or cause its relevantAffiliate to cease or divest, or cause its relevant Affiliate to divest ( whether by license or otherwise ) in accordancewith Section 15.2.2 subsequent to a merger, consolidation or acquisition ( including through a Change of Control ), ineach case ( ( a ) through ( c ) ) in the Field or, prior to the Schizophrenia 43Expiration Date, in Schizophrenia ; ( ii ) the expiration of the Term ; ( iii ) the effective date of termination of thisAgreement in its entirety pursuant to Article 11 ; or ( iv ) the effective date of termination by [COMPANY] pursuant toSection 11.2.5(a)(2 ) . For purposes of clarity, Initiation of a Clinical Trial for a Secondary Pharmacology Compoundshall not trigger the termination of the Option Term